Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022

神経修復・神経再生の世界市場予測(~2022年)

◆タイトル:Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022
◆商品コード:MAM-MD-3642
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年11月10日
◆ページ数:124
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、神経修復・神経再生の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、製品別分析、地域別分析、神経修復・神経再生の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The nerve repair and regeneration market is expected to reach USD 10.59 million by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, technological advancements, and rising geriatric population are driving the growth of this market. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.Neurostimulation and neuromodulation devices segment is expected to account for the largest share in the market
On the basis of product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. In 2017, the neurostimulation and neuromodulation devices segment is expected to account for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders and favorable reimbursement policies.
Internal neurostimulation and neuromodulation surgeries segment is expected to register the highest CAGR during the forecast period
Based on application, the nerve repair and regeneration market is segmented into into internal neurostimulation and neuromodulation surgeries and external neurostimulation and neuromodulation surgeries. The internal neurostimulation and neuromodulation surgeries segment is expected to register highest growth rate during the forecast period. This growth can be attributed to its wide application in neurological disorders.
North America is expected to account for the largest regional segment in the market
Geographically, the nerve repair and regeneration market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and growing incidence of peripheral nerve injuries.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1 – 35%, Tier 2 – 22% and Tier 3 – 43%
• By Designation – C level – 15%, Director level – 32%, Others – 53%
• By Region – North America – 32%, Europe – 27%, Asia – 22%, RoW – 19%

Key players operating in the nerve repair and regeneration market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US).
Study Coverage:
The report analyses the nerve repair and regeneration market by product, applications, end user, and regions. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.
Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

• Market Penetration: The report analyzes the nerve repair and regeneration market by product, application, and end user
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the nerve repair and regeneration market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various nerve repair and regeneration product across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the nerve repair and regeneration market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 16
2.1.1.1 Key data from secondary sources 16
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 17
2.2 MARKET SIZE ESTIMATION 18
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4 RESEARCH ASSUMPTIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 NERVE REPAIR AND REGENERATION: MARKET OVERVIEW 25
4.2 ASIAN NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION AND COUNTRY 26
4.3 GEOGRAPHIC SNAPSHOT OF THE NERVE REPAIR AND REGENERATION MARKET 27
4.4 NERVE GRAFTING MARKET, BY TYPE 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 High incidence of nerve injuries 29
5.2.1.2 Rising geriatric population and subsequent growth in the prevalence of neurological disorders 29
5.2.1.3 Technological advancements 29
5.2.2 RESTRAINTS 30
5.2.2.1 Greater preference for drug therapies over nerve repair and regeneration products 30
5.2.2.2 Dearth of trained professionals 30
5.2.3 OPPORTUNITIES 30
5.2.3.1 Emerging markets 30
5.2.3.2 Potential of stem cell therapy in nerve repair and regeneration 31
5.2.4 CHALLENGES 31
5.2.4.1 Donor-site morbidity 31
5.2.4.2 Difficulties in treating large nerve gaps 31
5.2.4.3 Stringent regulatory frameworks and time-consuming approval processes 31
6 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT 32
6.1 INTRODUCTION 33
6.2 NEUROSTIMULATION AND NEUROMODULATION DEVICES 34
6.2.1 INTERNAL NEUROSTIMULATION DEVICES 35
6.2.1.1 Spinal cord stimulation 36
6.2.1.2 Deep brain stimulation 36
6.2.1.3 Vagus nerve stimulation 37
6.2.1.4 Sacral nerve stimulation 38
6.2.1.5 Gastric electrical stimulation 38
6.2.2 EXTERNAL NEUROSTIMULATION DEVICES 39
6.2.2.1 Transcutaneous electrical nerve stimulation 40
6.2.2.2 Transcranial magnetic stimulation 41
6.3 BIOMATERIALS 42
6.3.1 NERVE CONDUITS 42
6.3.2 NERVE PROTECTORS 43
6.3.3 NERVE WRAPS 44
6.3.4 NERVE CONNECTORS 44
7 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION 45
7.1 INTRODUCTION 46
7.2 NEUROSTIMULATION AND NEUROMODULATION SURGERIES 47
7.2.1 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 48
7.2.2 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 48
7.3 DIRECT NERVE REPAIR/NEURORRHAPHY 49
7.3.1 EPINEURAL REPAIR 50
7.3.2 PERINEURAL REPAIR 50
7.3.3 GROUP FASCICULAR REPAIR 51
7.4 NERVE GRAFTING 51
7.4.1 AUTOGRAFTS 52
7.4.2 ALLOGRAFTS 53
7.4.3 XENOGRAFTS 53
7.5 STEM CELL THERAPY 54
8 NERVE REPAIR AND REGENERATION MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOSPITALS & CLINICS 57
8.3 AMBULATORY SURGERY CENTERS 58
9 NERVE REPAIR AND REGENERATION MARKET, BY REGION 59
9.1 INTRODUCTION 60
9.2 NORTH AMERICA 62
9.2.1 US 66
9.2.2 CANADA 67
9.3 EUROPE 69
9.4 ASIA 73
9.4.1 CHINA 77
9.4.2 JAPAN 77
9.4.3 INDIA 78
9.4.4 REST OF ASIA 79
9.5 REST OF THE WORLD 80
10 COMPETITIVE LANDSCAPE 83
10.1 INTRODUCTION 83
10.2 MARKET SHARE ANALYSIS 83
10.3 COMPETITIVE SITUATION AND TRENDS 84
10.3.1 REGULATORY APPROVALS 85
10.3.2 MERGERS AND ACQUISITIONS 85
10.3.3 PRODUCT LAUNCHES 85
10.3.4 AGREEMENTS, COLLABORATION AND PARTNERSHIPS 86
11 COMPANY PROFILES 87
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 AXOGEN 87
11.2 BAXTER 89
11.3 BOSTON SCIENTIFIC 91
11.4 LIVANOVA 94
11.5 INTEGRA LIFESCIENCES 96
11.6 MEDTRONIC 98
11.7 ABBOTT LABORATORIES 101
11.8 STRYKER 104
11.9 POLYGANICS 106
11.10 NUVECTRA 108
11.11 NEUROPACE 109
11.12 ORTHOMED 110
11.13 NEVRO 111

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 113
12.1 INSIGHTS OF INDUSTRY EXPERTS 113
12.2 DISCUSSION GUIDE 114
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 116
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 118
12.5 AVAILABLE CUSTOMIZATIONS 120
12.6 RELATED REPORTS 121
12.7 AUTHOR DETAILS 122

LIST OF TABLES

TABLE 1 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 33
TABLE 2 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 34
TABLE 3 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY REGION, 2015–2022 (USD MILLION) 34
TABLE 4 INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 35
TABLE 5 INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 35
TABLE 6 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 36
TABLE 7 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 37
TABLE 8 VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 37
TABLE 9 SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 38
TABLE 10 GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 39
TABLE 11 EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 39
TABLE 12 EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 40
TABLE 13 TENS DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 14 TMS DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 15 BIOMATERIALS MARKET, BY TYPE, 2015–2022 (USD MILLION) 42
TABLE 16 BIOMATERIALS MARKET, BY REGION, 2015–2022 (USD MILLION) 42
TABLE 17 NERVE CONDUITS MARKET, BY REGION, 2015–2022 (USD MILLION) 43
TABLE 18 NERVE PROTECTORS MARKET, BY REGION, 2015–2022 (USD MILLION) 43
TABLE 19 NERVE WRAPS MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 20 NERVE CONNECTORS MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 21 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 46
TABLE 22 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 47
TABLE 23 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET,
BY REGION, 2015–2022 (USD MILLION) 47
TABLE 24 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 25 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 26 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE,
2015–2022 (USD MILLION) 49
TABLE 27 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 28 EPINEURAL REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 29 PERINEURAL REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 30 GROUP FASCICULAR REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 31 NERVE GRAFTING MARKET, BY TYPE, 2015–2022 (USD MILLION) 51
TABLE 32 NERVE GRAFTING MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 33 AUTOGRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 34 ALLOGRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 35 XENOGRAFT MARKET, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 36 STEM CELL THERAPY MARKET, BY REGION, 2015–2022 (USD MILLION) 54
TABLE 37 NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 56
TABLE 38 NERVE REPAIR AND REGENERATION MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2015–2022 (USD MILLION) 57
TABLE 39 NERVE REPAIR AND REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 40 NERVE REPAIR AND REGENERATION MARKET, BY REGION,
2015–2022 (USD MILLION) 60
TABLE 41 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 42 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET,
BY PRODUCT, 2015–2022 (USD MILLION) 64
TABLE 43 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 64
TABLE 44 NORTH AMERICA: INTERNAL NEUROSTIMULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 45 NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 46 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 47 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 66
TABLE 48 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET,
BY END USER, 2015–2022 (USD MILLION) 66
TABLE 49 US: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 67
TABLE 50 NEUROLOGICAL CONDITIONS IN CANADA 68
TABLE 51 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 68
TABLE 52 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 69
TABLE 53 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 70
TABLE 54 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 55 EUROPE: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 70
TABLE 56 NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 71
TABLE 57 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2015–2022 (USD MILLION) 71
TABLE 58 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 72
TABLE 59 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 72
TABLE 60 ASIA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 74
TABLE 61 ASIA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 74
TABLE 62 ASIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 74
TABLE 63 ASIA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 64 ASIA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 65 ASIA: BIOMATERIALS MARKET, BY TYPE, 2015–2022 (USD MILLION) 75
TABLE 66 ASIA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 76
TABLE 67 ASIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 76
TABLE 68 CHINA: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 77
TABLE 69 JAPAN: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 78
TABLE 70 INDIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 78
TABLE 71 ROA: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 79
TABLE 72 ROW: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 80
TABLE 73 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY TYPE, 2015–2022 (USD MILLION) 80
TABLE 74 ROW: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 81
TABLE 75 ROW: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 81
TABLE 76 ROW: BIOMATERIALS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 77 ROW: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 82
TABLE 78 ROW: NERVE REPAIR AND REGENERATION MARKET, BY END USER,
2015–2022 (USD MILLION) 82
TABLE 79 GROWTH STRATEGY MATRIX, 2014–2017 84
TABLE 80 REGULATORY APPROVAL, 2014–2017 85
TABLE 81 MERGERS AND ACQUISITIONS, 2014–2017 85
TABLE 82 PRODUCT LAUNCHES, 2014–2017 85
TABLE 83 AGREEMENTS, COLLABORATION, AND PARTNERSHIPS, 2014–2017 86


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: NERVE REPAIR & REGENERATION MARKET 15
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 18
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 DATA TRIANGULATION METHODOLOGY 20
FIGURE 6 NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2017 VS. 2022 (USD BILLION) 22
FIGURE 7 NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2017 VS. 2022 (USD BILLION) 23
FIGURE 8 NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER,
2017 VS. 2022 (USD BILLION) 23
FIGURE 9 NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION,
2017 VS. 2022 (USD BILLION) 24
FIGURE 10 HIGH INCIDENCE OF NERVE INJURIES AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE MARKET GROWTH 25
FIGURE 11 NEUROSTIMULATION AND NEUROMODULATION SURGERIES TO DOMINATE THE ASIAN NERVE REPAIR AND REGENERATION MARKET IN 2017 26
FIGURE 12 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 27
FIGURE 13 XENOGRAFTS WILL CONTINUE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 27
FIGURE 14 NERVE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 28
FIGURE 15 NEUROSTIMULATION AND NEUROMODULATION DEVICES, THE LARGEST PRODUCT SEGMENT IN THE MARKET 33
FIGURE 16 NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 46
FIGURE 17 HOSPITALS & CLINICS SEGMENT TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD 56
FIGURE 18 NORTH AMERICA TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN 2017 60
FIGURE 19 ASIA TO REGISTER THE HIGHEST CAGR IN THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD 61
FIGURE 20 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 63
FIGURE 21 ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 73
FIGURE 22 NERVE REPAIR AND REGENERATION MARKET: MARKET SHARE (2016) 83
FIGURE 23 AXOGEN: COMPANY SNAPSHOT (2016) 87
FIGURE 24 BAXTER: COMPANY SNAPSHOT (2016) 89
FIGURE 25 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2016) 91
FIGURE 26 LIVANOVA: COMPANY SNAPSHOT (2016) 94
FIGURE 27 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2016) 96
FIGURE 28 MEDTRONIC: COMPANY SNAPSHOT (2016) 98
FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016) 101
FIGURE 30 STRYKER: COMPANY SNAPSHOT (2016) 104
FIGURE 31 NERVO: COMPANY SNAPSHOT (2016) 111


【レポートのキーワード】

神経修復、神経再生、生体材料、神経細胞保護剤、神経刺激装置、神経移植、幹細胞治療

★調査レポート[神経修復・神経再生の世界市場予測(~2022年)] ( Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022 / MAM-MD-3642) 販売に関する免責事項
[神経修復・神経再生の世界市場予測(~2022年)] ( Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022 / MAM-MD-3642) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆